Berberine, a potential drug for trachoma.
The clinical serological response to topical treatment of trachoma with Berberine an indigenous drug has been studied in 32 microbiologically confirmed cases. Efficacy of Berberine 0.2% when compared to sulfacetamide 20% was found to be superior in both the clinical course of trachoma and in achieving a fall in the serum antibody titers (P < 0.05) against chlamydia trachomatis in the treated patients.
Khosla
P K
PK
Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi.
Neeraj
V I
VI
Gupta
S K
SK
Satpathy
G
G
D001599:Berberine / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D013409:Sulfacetamide / Q000627:therapeutic use; D014141:Trachoma / Q000188:drug therapy*
D001599:Berberine; D013409:Sulfacetamide